NGF and Alzheimer disease: We reported a wide range of NGF activity in a cohort ranging from early to late-onset AD cases and some of the highest and lowest levels of NGF were seen in end-stage AD cases (Scott et al., 1995), suggesting that within a given cohort, NGF levels can be differentially affected by age at disease onset or differences in disease process.